Catalyst Wire Dossier Catalyst Wire Dossier

Fluticasone Furoate/Umclidinium Bromide/Vilanterol

· GlaxoSmithKline
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Fluticasone Furoate/Umclidinium Bromide/Vilanterol, covering 2019-07-15 to 2019-07-15. Get the full timeline:

Most recent: Clinical Trial Update: Comparative Study of Fluticasone Furoate(FF)/Umeclidinium Bromide (UMEC)/ Vilanterol (VI) Closed Therapy Versus FF/VI Plus UMEC Open Therapy in Subjects With Chronic Obstructive Pulmonary Disease (COPD) [Phase 3]

See pricing